Navigation Links
Neogen Forms Mexican Subsidiary
Date:6/10/2008

LANSING, Mich., June 10 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today the formation of its new subsidiary in Mexico, Neogen Latino America SPA. The new company, headquartered in Mexico City, will distribute the company's food and animal safety products throughout Mexico.

Neogen Latino America unifies Neogen's widespread business activities throughout Mexico to animal and crop producers, and food processors. The new company will also work with the United States and Mexico on programs to ensure the safety of food products that move across the border from either country. As a result of nearly 20 years of use, Neogen products have earned the trust of Mexican producers of meat and milk, and food processors.

"Much as we did earlier with the acquisition of our Scottish and German food safety distributors, we now see an opportunity to greatly strengthen our presence in Mexico," said Lon Bohannon, Neogen's president. "We believe Mexico continues to hold unrealized opportunities for sales growth."

Approximately $40 million of Neogen's FY 2008 revenue came from international sources.

Neogen's new company will start business with a revenue base of over $2 million (U.S.) that came from multiple sources in FY 2008. Jose Noriega, the former president of Biotecnologia Industrial, will manage the new company and own a minority interest.

"We are pleased to have Jose head the new company and direct our expansion," said Bohannon. "We have enjoyed a close relationship with him for 20 years as a distributor of Neogen's food safety products."

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.


'/>"/>
SOURCE Neogen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
2. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
3. Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues
4. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
5. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
6. Neogen Launches Quickest Test Available for Tetracyclines in Milk
7. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
8. Neogen Acquires Assets of Rivard Instruments
9. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
10. Neogen Acquires Kane Enterprises
11. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):